| 1 |
32058974 | Post-treatment with Posiphen Reduces Endoplasmic Reticulum Stress and Neurodegeneration in Stroke Brain. | 2020 Feb 21 |
3 |
| 2 |
28274151 | Pharmacophore-based design and discovery of (-)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis. | 2017 Dec |
1 |
| 3 |
22831800 | Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities. | 2012 Aug 15 |
3 |
| 4 |
20144867 | Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities. | 2010 Mar 1 |
1 |
| 5 |
17003227 | The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice. | 2007 Jan |
1 |
| 6 |
16248851 | Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects. | 2005 Oct |
1 |
| 7 |
12034133 | Tianeptine: 5-HT uptake sites and 5-HT(1-7) receptors modulate memory formation in an autoshaping Pavlovian/instrumental task. | 2002 May |
1 |
| 8 |
9675107 | Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine. | 1998 Jul 9 |
4 |
| 9 |
2709330 | Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases. | 1989 Apr |
1 |